Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;78(2):275-284.
doi: 10.1007/s40265-018-0871-0.

Semaglutide: First Global Approval

Affiliations
Review

Semaglutide: First Global Approval

Sohita Dhillon. Drugs. 2018 Feb.

Abstract

Novo Nordisk has developed a subcutaneous formulation of semaglutide (Ozempic®), a modified human glucagon-like peptide-1 (GLP-1) analogue, for the treatment of type 2 diabetes mellitus. It has been developed using Novo Nordisk's proprietary protein-acylation technology, and is administered using an injection device. Semaglutide lowers blood glucose by stimulating the release of insulin and also lowers body weight. Once-weekly subcutaneous semaglutide has recently been approved in the US, Puerto Rico and Canada, and has received a positive opinion in the EU for the treatment of patients with type 2 diabetes. It will be launched as the Ozempic® Pen, a pre-filled device. Semaglutide is also under regulatory review in Japan and Switzerland for the treatment of type 2 diabetes. Clinical development for obesity, non-alcoholic steatohepatitis and non-alcoholic fatty liver disease is underway worldwide. This article summarizes the milestones in the development of semaglutide leading to this first approval for type 2 diabetes.

PubMed Disclaimer

References

    1. Am Health Drug Benefits. 2017 Jun;10 (4):178-188 - PubMed
    1. Clin Pharmacokinet. 2017 Nov;56(11):1391-1401 - PubMed
    1. J Med Chem. 2015 Sep 24;58(18):7370-80 - PubMed
    1. Diabetologia. 2017 Aug;60(8):1390-1399 - PubMed
    1. Lancet Diabetes Endocrinol. 2017 May;5(5):355-366 - PubMed

MeSH terms

LinkOut - more resources